Home › Cancro della vescica › Minnesota › Rochester
Studi clinici su Cancro della vescica a Rochester, MN
12 studi su Cancro della vescica cercano partecipanti presso sedi a Rochester e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
In reclutamentoFase 3
- Mayo Clinic in Rochester, Rochester
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
In reclutamentoFase 4
- Mayo Clinic in Rochester, Rochester
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
In reclutamentoFase 2
- Mayo Clinic in Rochester, Rochester
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
In reclutamentoFase 1
- Mayo Clinic Rochester, Rochester
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
In reclutamentoStudio osservazionale
- Mayo Clinic (Rochester), Rochester
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
In reclutamentoFase 2
- Mayo Clinic Rochester, Rochester
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
In reclutamentoFase 2
- Mayo Clinic, Rochester
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
In reclutamentoStudio osservazionale
- Mayo Clinic in Rochester, Rochester
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
In reclutamentoFase 1/2
- Mayo Clinic, Rochester
Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
In reclutamentoFase 2
- Mayo Clinic in Rochester, Rochester
Bladder Bank (a Prospective Banking Study)
In reclutamentoStudio osservazionale
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Mayo Clinic, Rochester
Studi su Cancro della vescica in altre città
- New York City, NY35 studi
- Nashville, TN31 studi
- Houston, TX31 studi
- Dallas, TX27 studi
- Boston, MA26 studi
- Washington, DC26 studi
- Los Angeles, CA24 studi
- Baltimore, MD24 studi
- St. Louis, MO22 studi
- Philadelphia, PA21 studi
- Seattle, WA21 studi
- Edison, NJ21 studi
Altri studi a Rochester
- Cancro al seno42 studi
- Cancro del polmone non a piccole cellule37 studi
- Cancro metastatico31 studi
- Cancro (tutti i tipi)30 studi
- Cancro colorettale29 studi
- Cancro ovarico29 studi
- Mieloma multiplo24 studi
- Cancro alla prostata22 studi
- Insufficienza cardiaca22 studi
- Cancro pancreatico22 studi
- Cancro ai polmoni20 studi
- Cancro dell'endometrio20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.